Prognosis of Systolic Pressure 130 to 139 According to Risk. A Prospective Cohort Study Between 1992 and 2019

Author:

Divison-Garrote Juan A.123,Carbayo-Herencia Julio A.34ORCID,Simarro-Rueda Marta53ORCID,Molina-Escribano Francisca13ORCID,Escobar-Cervantes Carlos6ORCID,Artigao-Rodenas Luis M.3ORCID,Gil-Guillén Vicente478,Banegas José R.9ORCID

Affiliation:

1. Casas Ibáñez Primary Care Center (J.A.D.-G., F.M.-E.), Atención Primaria Albacete, Spain.

2. Department of Medicine, Universidad Católica de Murcia (UCAM), Spain (J.A.D.-G.).

3. GEVA (Grupo Enfermedades Vasculares Albacete), Spain (J.A.D.-G., J.A.C.-H., M.S.-R., F.M.-E., L.M.A.-R., V.G.-G., J.R.B.).

4. Department of Clinical Medicine, Universidad Miguel Hernández de Elche, Alicante, Spain (J.A.C.-H., V.G.-G.).

5. Villamalea Primary Care Center (M.S.-R.), Atención Primaria Albacete, Spain.

6. Department of Cardiology, Hospital Universitario La Paz, Madrid, Spain (C.E.-C.).

7. Institute of Health and Biomedical Research of Alicante, Hospital General Universitario de Alicante, Spain (V.G.-G.).

8. Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Spain (V.G.-G.).

9. Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid/IdiPaz and CIBERESP, Madrid, Spain (J.R.B.).

Abstract

BACKGROUND: Guidelines recommend pharmacological treatment for systolic blood pressure (SBP) of 130 to 139 mm Hg in secondary prevention. However, uncertainty persists in primary prevention in low cardiovascular risk patients (CVR). METHODS: Cohort study representative of the general population of Albacete/Southeast Spain. We examined 1029 participants with untreated blood pressure and free of cardiovascular disease, followed-up during 1992 to 2019. Cox regression modeled the association of SBP with cardiovascular morbidity and mortality (outcome-1) and cardiovascular morbidity and all-cause mortality (outcome-2). RESULTS: Participants’ mean age was 44.8 years (53.8%, women; 77.1% at low-CVR); 20.3% had SBP 120 to 129; 13.0% 130 to 139 at low-CVR and 3.4% at high-CVR; and 27.4% ≥140 mm Hg. After a 25.7-year median follow-up, 218 outcome-1 and 302 outcome-2 cases occurred. Unadjusted hazard ratios of outcome-1 for these increasing SBP categories (versus <120) were 2.72, 2.27, 11.54, and 7.52, respectively; and 2.69, 2.32, 10.55, and 7.34 for outcome-2 (all P <0.01). After adjustment for other risk factors, hazard ratio (95% CI) of outcome-1 were 1.49 (0.91–2.44), 1.65 (0.94–2.91, P =0.08), 1.36 (0.72–2.57), and 1.82 (1.15–2.88), respectively, and 1.39 (0.91–2.11), 1.69 (1.05–2.73), 1.09 (0.63–1.88), and 1.64 (1.11–2.41) for outcome-2. Compared with 130 to 139 at low-CVR, hazard ratio for 130 to 139 at high-CVR was 4.85 for outcome-1 ( P <0.001) and 4.43 for outcome-2 ( P <0.001). CONCLUSIONS: In this primary prevention population of relatively young average age, untreated SBP of 130 to 139 mm Hg at low-CVR had long-term prognostic value and might benefit from stricter SBP targets. High-CVR patients had nonsignificant higher risk (limited sample size) but 4-fold greater risk when compared with low-CVR. Overall, results indicate the importance of risk stratification, supporting risk-based decision-making.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3